Ep18: Beyond the Gut Feeling: Unraveling the Mysteries of Visceral Pain

Welcome to the deep dive. Today, we're going to tackle visceral pain. You know, that often kind of puzzling discomfort that comes from our internal organs. Think of this as your shortcut, sort of, to understanding why it happens, how it's different, and maybe why your gut literally and figuratively might be acting up. Yeah, and it's something so many of you listening, probably no firsthand, even if you haven't had a specific name put to it, that intermittent abdominal pain that just flares up, or maybe chest pain that the doctors check out and say, "No, not your heart." Right. Or perhaps that really persistent pelvic pain. These things, they aren't just like minor inconveniences. They can seriously disrupt your day-to-day life. Oh, absolutely. And frustration is, well, it's really real, isn't it? You go through all these tests, you're hoping for an answer, and then you hear everything looks normal. It can leave you feeling pretty lost, wondering if it's, you know, all in your head. So, our goal with this deep dive is really to shed some light on why that might be the case, and what's actually going on with visceral pain. Exactly. We've basically immersed ourselves in the scientific literature, the research that's exploring how this kind of pain works, how we classify it, and, you know, the latest thinking on why it sometimes becomes chronic. Right. We're here to pull out the most important insights for you. We'll cover the neurobiology, like how these pain signals travel. The key differences between visceral pain and other types that really crucial distinction between different kinds of visceral pain and the sort of evolving ways we're understanding these often challenging conditions. Okay, so let's get down to it. What exactly is visceral pain? Fundamentally. Okay. So, simply put, visceral pain is pain that starts in the internal organs. We're talking chest, abdomen, pelvis. And it can be triggered by, well, various things, inflammation, and ongoing disease, actual damage, or even an injury to the organ. Right. What's interesting, though, is that this type of pain, it's actually the most common kind that brings people into the clinic. Wow, really most common. Yeah. And the IASP that's the International Association for the Study of Pain, they even have a specific definition for when it becomes chronic. They call it chronic secondary visceral pain, which is basically pain that keeps coming back, or just doesn't go away. And importantly, we can link it to a persistent identifiable problem with one of those internal organs. Okay, that makes sense. So, what makes this internal organ pain feel so different from, say, smacking your elbow or getting a paper cut, you know, somatic pain? Yeah, there's some really unique characteristics. One that often surprises people is something called selective evocation. Okay. It turns out that not all our internal organs will actually cause pain if they're stimulated in a way that would definitely hurt on the outside. For instance, you could theoretically cut or burn the visceral peritonium that's the lining around our abdominal organs, and it might not cause that sharp immediate pain you'd expect. We'd do that to the parietal peritonium, the lining of the abdominal wall, and that would hurt sharply. That's almost counterintuitive, really. You'd think damage is damage, right? So how can something be happening inside, but we don't feel it as a clear ouch? Exactly. And another key difference is that visceral pain can happen even when there's no obvious injury or disease that we can easily see on tests. This is super common in what we call functional syndromes, like IBS irritable bowel syndrome. Okay. Then there's the sensation itself. It's usually diffuse and poorly localized. People often describe it as like a deep vague ache or pressure. Right. Not sharp. Not sharp. Yeah. And often kind of centered in the midline, think around the lower chest upper abdomen area, rather than a specific spot you could point to like that paper cut. And why is it so hard to put your finger on exactly where it hurts? Well, a big part of that is the nerve supply. Our internal organs just have a lower density of sensory nerve endings compared to, say, our skin. Plus, the signals from these visceral nerves tend to spread out more widely within the central nervous system. Imagine like fewer phone lines trying to connect to a central hub. And those lines aren't always direct routes. Gotcha. It's very different from somatic pain signals, which are usually much more direct and localized. Okay. So it's vague, spread out. What other clues tell us it's likely visceral pain we're dealing with? Another really important clue is referral. Visceral pain can be referred to distant sites. Right. Like the shoulder pain with a heart attack. Exactly. Exactly that kind of thing. Yeah. You feel the pain in your skin or muscles, maybe quite far away from the organ that's actually the source of the problem. This happens because the nerves from the organ and the nerves from that distant spot share pathways. They converge onto the same neurons in the spinal cord. We can dig into the why of that more later. Okay. Also visceral pain often brings along a whole entourage of other bodily response to what we call autonomic and motor reflexes. Like feeling sick. Yeah. Thick nausea, sweating, maybe changes in your heart rate or blood pressure, feeling hotter, cold, even muscle tension. And finally, and this is really key, visceral pain tends to have a strong, effective or emotional component. Meaning, meaning it's not just a physical sensation. It often comes packaged with significant distress, anxiety, sometimes even anguish, or real feeling of being unwell. Yeah. It sounds incredibly disruptive to just living your life. Yeah. How widespread is this kind of pain? Is it common? Oh, unfortunately, it's very common. Conditions involving visceral pain, things like recurring abdominal issues that non-cordia, chest pain we mentioned, chronic pelvic pain, they affect a large percentage of adults. And yeah, it can seriously hammer quality of life. Plus, it creates a significant socio-economic burden, you know, healthcare costs, miswork, all that. Right. And like you said earlier, the fact that test often come back normal in these situations is a major source of frustration. It really highlights the need for a deeper understanding and frankly, more specialized ways to manage it. Okay, so let's peel back the layers then. How does this often elusive pain signal actually get from our organs all the way up to our brain? What's the underlying neurophysiology? Right. The journey starts with what are called visceral afferent fibers. Think of them as the sensory nerves in your organs. They're mostly thin, egg-elta and unmyelinated C fibers. Okay. Now, what's interesting here, unlike in our skin, the distinction between the fibers that specifically carry pain signals and those carrying other sensations isn't quite as clear cut in our organs. Hmm, less specialized. Sorta, yeah. These fibers connect to visceral receptors, little sensors in the organs detecting potentially harmful stuff. What kind of sensors are we talking about? What do they detect? Well, we have mechanosensitive receptors which respond to physical forces like stretching or pressure. Makes sense for organs. Yeah. Some of these are high thresholds. They only really get activated by intense stimuli. It thinks it's a significant distinction. Like if something's blocked or a ski me a lack of blood flow or a significant inflammation, you find these in the heart. Asophagus, colon, ureter, uterus, places like that. Okay. But, and this is really key for understanding a lot of chronic visceral pain. They're also low threshold or intensity encoding mechanosensitive receptors. Low threshold meaning more sensitive. Exactly. They respond to a much wider range of stimuli, even sort of normal movements or pressures within the organ. And crucially, the more intense the stimulus, the more rapidly they fire off signals. Okay. So they're like a volume dial that turns up the sensation depending on what's happening. That's a great way to put it. Yeah. And here's where it gets really interesting, especially for people experiencing chronic pain like IBS under certain conditions, maybe ongoing inflammation or even chronic stress. These low threshold receptors can become sensitized sensitized how like jumpy pretty much think of it like that volume knob getting suck on high or maybe becoming overly sensitive. They start firing off pain signals much more easily, even in response to things that wouldn't normally cause any pain at all. This is thought to be a major reason why people with conditions like IBS can feel pain from just normal gut function like gas moving through. That's aledonia pain from something not usually painful. Okay. That clicks. And hyperalgesia, an exaggerated response to something that might be only mildly uncomfortable otherwise. This is quite different from how our skin sense is normal touch, which involves different types of fibers that don't usually become pain sensitive in this way. That makes so much sense that even just normal gut rumbling could feel painful if these receptors are all hyped up. What other kinds of receptors are involved? We also have chemosensitive receptors. These guys are triggered by chemicals released during inflammation, things like bradykinin, prostaglandins, histamine, even changes in acidity. So chemical alarms? Right. So might be quite specific responding only to certain inflammatory molecules. And then there's another fascinating group, the silent or mechanically insensitive no-susceptors, sometimes called MIAs. Silent. Meaning they don't usually do anything. Exactly. Normally they're just sitting there unresponsive to mechanical stuff like stretching. But if there's significant inflammation or tissue injury nearby, they can suddenly wake up, become active, and start responding to mechanical inputs. Wow. So they get recruited when things get bad. Precisely. Yeah. They act like a sort of reserve force. Their recruitment can really amplify the overall pain signal and might play a role in why pain can become chronic after an initial injury or inflammation resolves. So these silent ones are like a backup alarm system that only goes off in a real emergency inside. That's a good analogy. Yeah. Their activation definitely contributes to making the pain feel worse. Okay. So once these various receptors are activated, how do the signals actually get to the central nervous system? Write the pathways. There are a few main routes. Most visceral pain signals travel via spinal afferent five. numbers. The nerve cell bodies are in the dorsal root ganglia. Think of them as relay stations just outside the spinal cord. Okay. And from there, they project into specific layers or laminate within the spinal cord itself, mostly laminate I, V, and deeper layers like X. Got it. Spinal road is primary. It is for most pain signals, yes. But a significant number of signals also travel within the vagus nerve. Ah, the vagus nerve. Heard a lot about that with the gut brain connection. Exactly. It is a major player. These vagal aphoranes have their cell bodies elsewhere in the nodos ganglion. And they mainly project to a part of the brain stem called the nucleus tract of solitary eye or NTS. And what does the vagus nerve signal usually? Traditionally, it is more associated with signaling physiological status, like feeling full after eating or feeling nauseous. But it definitely plays a role in modulating pain perception and those autonomic reflexes we talked about. It is a key communication highway in that whole brain gut access. Interesting. Any other pathways? There's actually some evidence suggesting that a small portion of visceral pain signals might also travel up the spinal cord via the dorsal column pathway, which is usually associated more with fine touch and proprioception, still being researched that one. Okay, so the signals make their way to the spinal cord. Maybe the brain stem via the vagus nerve. What happens once they get into the central nervous system? How are they processed? Right. The processing that happens right there in the spinal cord is really critical. One key phenomenon is called visceral somatic convergence. Visceral somatic organ and body convergence. Exactly. This is where nerve fibers coming from our internal organs and nerve fibers coming from our skin and muscles actually meet up. They synapse on or connect with the same nerve cells in the spinal cord. And that's the referred pain mechanism. That's the main biological basis for referred pain. Yes. The brain basically gets a signal from that shared spinal cord neuron and misinterprets it as coming from the more familiar somatic location like the skin or muscle, rather than the internal organ. That shoulder pain during a heart attack is the classic example. It also means there can be a two way street of influence. For example, inflammation in an organ like the gallbladder can sometimes make the overlying skin area feel tender or more sensitive and these connections aren't static. They can change. Chronic visceral problems can actually lead to long lasting changes, making those related somatic areas persistently hypersensitive. This is called neuroplasticity. So the system adapts, but maybe not in a good way. Sometimes. Yeah. But it also hints at possibilities, like maybe targeting those somatic areas with certain therapies could counterintuitively help produce the perception of the visceral pain because they share that spinal circuitry. Wow. That's mind blowing. So like a tennis machine on your back could potentially help with say gut pain. It's theoretically possible, depending on the specific nerve connections involved. Yeah. It's an area of active research. Another important aspect of spinal cord processing is extensive divergence. Divergence spreading out. Exactly. Unlike somatic signals from the skin, which tend to follow more specific localized pathways, the nerve terminals from our internal organs spread out quite widely, connecting with many different neurons across multiple levels or segments of the spinal cord, contributing to that vague, hard to pinpoint feeling precisely. That contributes significantly to the diffuse quality of visceral pain. And then there's a really big one, central sensitization. Okay, heard that term a few times now. Break it down. So if the input coming from the viscera is prolonged or very intense, it can make the nerve cells in the spinal cord, those dorsal horn neurons become hyper excitable, like turning up the gain on an amplifier. Perfect analogy. Everything gets louder and more sensitive. This central sensitization amplifies the pain signals traveling up to the brain. It lowers the threshold for what triggers pain. It's aloudunia again. Right. It exaggerates the response to things that are painful, hyperalgesia. And it can even expand the receptive fields, meaning pain is felt over a larger area than just the original source. How does that happen? Mechanistically. Key mechanisms involve the activation of specific receptors on the nerve cells, like the NMDA receptor, and changes in the function of various ion channels that control how easily the neurons fire. It's like the spinal cord learns to be overreactive to signals from that organ. So the spinal cord itself can get kind of stuck in a high alert state for pain from our organs. What happens when those amplified signals finally reach the brain? They travel up to higher brain centers, view several ascending pathways. The spinal flamic tract is a major one, also the spinal-articular tract, and possibly that dorsal column pathway too. And where in the brain do they go? A whole network lights up really. Key regions include the thalmas, which is like a central relay station, the somatosensory cortices, SI and SII, where we process touch and location. The insular cortex, crucial for introseption, our sense of the body's internal state, the anterior singulate cortex, ACC. The prefrontal cortex, the amygdala involved an emotion, hypothalamus, and brainstem areas like the periocoductal gray, and the NTS we mentioned earlier. Wow, quite a network. You mentioned the emotional aspect earlier too. Yes, and this brain processing really highlights that. What's striking about visceral pain is its strong, effective motivational dimension. The fact that signals are heavily processed in limbic areas like the ACC, the insular, the amygdala helps explain why it often comes with such powerful emotional responses. The anxiety, the depression, the fear. Exactly. The suffering component. It's not just a sensory discrimination task for the brain. It's a powerful emotional experience. This really underscores why psychological therapies can be so important in managing chronic visceral pain. Makes sense. And one more thing about the brain. It's not just receiving signals. It also sends signals down to the spinal cord via descending pathways, originating in areas like the peg, and another brainstem region called the RVM. These descending pathways can either inhibit pain signals, turn the volume down, or facilitate them turn the volume up. So the brain can control the pain signals. It tries to, yeah. But in many chronic visceral painstays, there seems to be a dysregulation of this system, often with a shift towards facilitation, meaning the brain is actually amplifying the pain signals coming up from the spinal cord. Okay, we've covered a lot of the plumbing and wiring, so to speak. Let's step back and really contrast visceral pain with somatic pain that everyday pain from skin, muscles, joints. Can we summarize the key differences clearly? Absolutely. Let's break it down. Origin. Internal organs versus outer body tissues. Right. Obvious one. Quality. Visceral is often dull, deep, crampy, maybe poorly localized. Somatic can be sharp, aching, throbbing, usually easier to pinpoint. Localization. Visceral is diffused. Somatic is more precise. Referral, common with visceral, much less so with somatic. Neurofibers and receptors. Different types involved, lower density and osseceptors generally, and viscera compared to skin. Viscera have those unique intensity and coding and silent types we discussed. CNS processing. Visceral signals show that wide divergence in the spinal cord leading to diffuse sensation. Somatic is more organized. Visceral is somatic convergence is key for visceral referral. Autonomic signs are much more prominent with visceral pain, technology, sweating, heart rate changes, less common with typical somatic pain. And the emotional component. Generally much stronger, more distressing with visceral pain. Okay, that's a good summary. And you mentioned earlier that the intensity of visceral pain doesn't always match the amount of actual tissue damage, unlike say a deep cut. Why is that such a crucial difference to grasp? It's really fundamental because it highlights that in visceral pain, factors within the central nervous system, things like central sensitization, descending modulation, and also psychological factors, play a much stronger role in determining the perceived intensity of the pain. So it's not just about the injury signal itself. Exactly. It means just looking for a physical injury or disease in the organ might not be enough to fully understand or effectively treat the pain. You absolutely have to consider these central and psychological components as well. Right. Let's dig just a little deeper into those underlying differences in nerve supply and brain processing again to really cement it. Sure. So innervation density. Generally, lower in narcissistic density in viscera than skin. Okay, affront fiber types. Viscera have those unique properties like the intensity and coding low threshold ones that can become sensitized to non-painful stimuli and the MIAs, the silent ones. The somatic system has a beta fibers for non-painful touch, which usually don't signal pain. And CNS processing that extensive divergence of visceral pathways versus the more point to point organized projections for somatic sensation is key. Right. The spread out feeling. Yeah. And the brain's representation, the map of visceral sensation in these sensory cortex is much less distinct, more diffuse compared to the detailed somatotopic map we have for our skin and muscles. Like you can tell exactly which finger is touched, but not exactly which part of your intestine aches. Precisely. And again, that viscera somatic convergence at the spinal cord level remains a crucial distinction explaining referred pain and that potential for two-way sensitization between organs and body wall structures. You also touched on how our development as embryos plays a role in these referral patterns. Can you expand on that a bit? It sounds fascinating. It really is quite cool. The patterns often reflect shared developmental origins. Organs and somatic structures that arise from the same embryonic segments might retain shared nerve connections in the central nervous system. Even if they end up physically far apart in the adult body. Like the diaphragm and shoulder example. Exactly. They get nerve input from similar spinal cord levels during development. C3, C4, C5 mainly. So irritation of the diaphragm may be from gallbladder inflammation underneath it. Contriger nerves. signals that travel to those final segments. The brain, receiving signals from neurons that also get input from the shoulder area via those same segments, misinterprets the signal that's coming from the shoulder. So the brain assumes it's the more common source. That's the essence of the convergence projection theory, yeah. The brain projects the sensation to the somatic area that shares the same central connections. Right. And then you have the peritonium difference. Right, the linings. The parietal peritonium lining the abdominal wall has somatic innervation sensor. Lots of specific nerves. Eurotation there, like if appendicitis spreads, causes sharp, localized pain. But the visceral peritonium covering the organs and the tissues just beneath it have autonomic innervation. A pain from there tends to be duller, midline and often referred. And appendicitis is the classic example of this switch. It's prime example. Early on, when inflammation is just in the appendix itself, visceral peritonium, the pain is often vague. Maybe you're on the belly button, midline, poorly localized. Okay. But as the inflammation worsens and irritates the overlying parietal peritonium, the pain typically shifts and becomes sharp, intense and localized to the right lower quadrant. That change in pain character perfectly illustrates the difference between visceral and parietal somatic pain processing. That example really clarifies it. Okay. It shifts gears to a distinction that seems increasingly important, primary versus secondary visceral pain. What's the fundamental difference here? This is a really critical distinction. Formally recognized now in classifications like the ICD-11. Chronic secondary visceral pain is pain that's persistent or recurrent, lasts more than three months, comes from internal organs. But the key is there's an identifiable underlying disease, lesion or dysfunction in that organ causing it. And ongoing inflammation, a blockage, a tumor. Exactly. Something we can point to. The pain is primarily driven by ongoing activation or sensitization of NOS receptors at the site of that pathology, what we call primary hyperalgesia. This peripheral input can then of course lead to central sensitization and referred pain too. Okay. So secondary means you can find a clear culprit in the organ. What about primary visceral pain then? Chronic primary visceral pain, CPVP, is also chronic pain again, more than three months in the chest, abdomen or pelvis, but the defining feature is the absence of an identifiable structural disease or organic lesion that adequately explains the pain. So the tests might look normal, essentially. Often, yes. CPVP is now understood not just as unexplained pain, but as a condition, a disease entity in its own right. It's thought to involve fundamental alterations in how the central nervous system processes pain signals. Ah, so the problem is more in the processing, not the organ structure itself. Precisely. We're talking about mechanisms like central sensitization, the concept of NOSA plastic pain, pain arising from altered NOSAception itself, visceral hypersensitivity, and dysradiilation of that brain gut axis we keep mentioning. Genetic factors, hormones, metabolism, and psychological factors can all contribute to this altered processing state. So this is a big shift, right, recognizing it as its own thing. It's a huge paradigm shift. It helps validate the experiences of millions of people whose pain didn't fit neatly into boxes tied to organ damage. It reduces stigma, guides more appropriate treatment, moving beyond just looking for lesion effects, and focuses research on understanding these underlying neurobiological changes. How do clinicians actually go about differentiating between primary and secondary visceral pain in practice? What are the key diagnostic signs they look for? Well, as we said, the core distinction is the presence or absence of that identifiable relevant organ pathology. For secondary pain, you need evidence often from at least one confirmatory test, as the IASP puts it, showing organ dysfunction that's likely causing the pain. For primary pain, the diagnosis relies on the typical pain characteristics, location duration, the significant emotional distress and/or functional disability causes, and the exclusion of structural disease that could explain it. So ruling things out is still part of it for primary pain? Yes, ruling out serious underlying pathology that would constitute secondary pain as crucial. But the emphasis then shifts to positively identifying features consistent with primary pain. The chronic nature or the impact may be signs of widespread sensitivity. Right. It's important to note a nuance, though. Even in secondary pain, the intensity of pain doesn't always correlate neatly with the severity of the disease seen on tests. And crucially, secondary pain can evolve. Even if the original organ problem is treated or resolves, the central nervous system changes that central sensitization might persist. So what started as secondary pain can sometimes transition into a mixed state or even a predominantly primary no-soplastic pain condition over time, the diagnosis might actually shift. That makes sense. The nervous system can kind of get stuck in that pain mode. So how does making this distinction between primary and secondary actually impact the diagnostic approach and, more importantly, the treatment strategies? It is really significant clinical implications. Diagnostically, for secondary pain, the focus is laser sharp on identifying and characterizing that underlying organ problem. Find the cause, treat the cause. Pretty much. Treatment targets the underlying disease with pain relief often as an adjunct. For primary pain, however, one serious pathology is ruled out that diagnostic focus shifts. We look closely at the pain characteristics, the functional impact, psychological comorbidities, maybe even look for clinical science suggestive of altered pain processing, like widespread tenderness. And the treatment reflects that difference. Absolutely. Treatment for primary pain needs to be much more comprehensive, often multimodal, and biopsychosocial. We might use neuromodulators' medications that target nerve signaling and central sensitization alongside non-drug approaches. Like therapy? Yes. Psychological therapies like CBT or ACT. Physical therapy may be focusing on function or relaxation, dietary changes. Like lifestyle adjustments. The goal is often broader than just pain reduction. It's about reducing distress, improving function, improving quality of life, maybe retraining the pain system. It also sounds like managing expectations is key, especially for primary pain. Definitely. Complete pain elimination might be less realistic than functional improvement for many with primary visceral pain. Setting realistic goals is crucial. And this distinction is vital for research too, ensuring we study comparable patient groups. Plus, accurate diagnosis of primary pain can potentially save health care resources by avoiding endless fruitless searches for structural cause. Okay. Let's move on to how we actually categorize these chronic visceral pain syndromes. You mentioned functional gut disorders earlier and how that understanding has evolved, especially with the Rome criteria. Absolutely. When we talk about functional gastrointestinal disorders or FGIDs, which are now increasingly called disorders of gut brain interaction, DGBI, the Rome criteria have been central. They've evolved quite a bit. From Rome out to Rome third. Exactly. Start back in the late 80s, early 90s with people like Chaudhary, True Love, and Manning, laying groundwork. Rome, I was the first big consensus effort, focusing on anatomical domains and symptom-based criteria. Rome two expanded things, included pediatrics, considered pharma use. Rome third pushed for more evidence-based criteria. And Rome third, what's the big change there? Rome the third, published in 2016, really embraced the concept of DGBI. It simplified some criteria and strongly emphasized these conditions as disorders of the gut brain interaction, not just unexplained symptoms. The criteria generally require symptoms for at least three months, with onset six months prior. Then the Rome Foundation drives this. Yes, they coordinate this international effort. The big conceptual leap has been moving away from diagnoses of exclusion. It's IBS because we can't find anything else. Towards positive clinical entities, defined by specific symptom clusters, underpinned by this understanding of neurobiological dysregulation in the gut brain axis. What drove that shift away from just focusing on organs towards symptom clusters in this gut brain idea? Was it just the lack of findings? That was a huge part of it. In so many patients, tests just didn't show clear structural or biochemical problems to explain the symptoms. So the focus shifted to the symptoms themselves, and researchers noticed these symptoms often clustered together. Ah, patterns emerged. Right. Which led to codified diagnostic entities like those in the Rome criteria. The DGBI concept then provides the explanatory framework. It highlights dysregulation across several areas, motility, how the gut moves, visceral hypersensitivity, how sensations are perceived, mucosal and immune function within the gut lining, the gut microbiota, the bacteria living there, and critically central nervous system processing, including the impact of stress and emotion. But Rome to force specifically brought in the microbiota and immune function more. Yes. That was a key update in Rome for explicitly acknowledging the roles of altered microbiota and low grade mucosal inflammation or immune changes. Really opened the door wider for research into and potentially use of gut targeted therapies like specific diets, probiotics, maybe even fecal microbiota transplantation, some contexts, aiming to modulate that gut environment to influence the brain gut axis. Can you give us a few quick examples of these DGBI's and their key features under Rome 4th, just to illustrate? Sure. Let's take irritable bowel syndrome, IBS. The core criterion is recurrent abdominal pain, on average at least one day per week in the last three months, associated with two or more of the following. Related to defecation, associated with a change in stool frequency, or associated with a change in stool form or appearance. Okay. Pain plus bowel habit changes. Exactly. And there's functional dyspepsia up at the stumbachyper abdomen area. This splits into two main types, post-brandial distress syndrome, bothersome fullness after eating, feeling full too early, or epicastric pain syndrome, bothersome pain or burning in the upper abdomen. Again, these symptoms are very serious. symptoms need to be chronic, and no structural disease explains them. Got it. Functional heartburns, another burning chest pain, but it doesn't respond well to standard acid suppression therapy, and there's no evidence of reflux causing it, or majorisophageal motility problems. So heartburn feeling, but not typical heartburn causes? Right. And then there's a condition called centrally mediated abdominal pain syndrome, C-A-P-S. This involves chronic or near continuous abdominal pain. It's typically not related, or only occasionally related, to gut function, like eating or bowel movements. It causes significant loss of daily function, and importantly, the pain can't be explained by another DGBI or structural metabolic issue. It's thought to be driven primarily by central nervous system mechanisms. Okay. Those examples really highlight the symptom focus. What are the key underlying mechanisms thought to drive these DGBI's overall? Two really big ones as we've touched on are visceral hypersensitivity, and that altered gut brain access communication. Visceral hypersensitivity, again, the gut being too sensitive. Essentially, yes, an increased perception of sensations arising from the visceral, lower pain threshold, to stimuli like gut distension stretching, or an exaggerated response to even normal levels of stimuli. We can actually measure this sometimes with specialized tests using balloons in the gut, called barostats studies. And what causes that hypersensitivity? It's complex, likely involving both peripheral sensitization nerves in the gut wall, becoming hyperexcitable, perhaps due to low grade inflammation, altered microbiota, or nerve changes, and central sensitization in this spinal cord and brain amplifying those signals. Okay. And the altered gut brain access. This encompasses several interconnective factors. Microbial dysbiosis is one in imbalance in the gut bacteria. Changes in the types, diversity, or function of microbes. How does that affect things? Well, dysbiosis can potentially increase gut permeability, leaky gut, allowing bacterial products like lipo polysaccharide LPS to cross the gut barrier, triggering inflammation and sensitizing nerves locally, and potentially even affecting the brain. Gut bacteria also produce neuroactive substances, neurotransmitters, short-chain fatty acids that can influence gut motility, sensation, and brain function. Wow. What else in the access? Vegas nerve dysfunction. As the main nerve highway altered signaling up from the gut, it can lead to abnormal brain processing, and impaired signaling down effort might affect things like the gut's anti-inflammatory pathways. And the HPA access the stress system. Huge player. Hypothelamic pituitary adrenal axis dysregulation, often linked to chronic stress, can alter cortisol levels and activity. Chronic stress mediators like corticotropin releasing hormones, C.R.H., directly impact gut motility, secretion permeability, and visceral sensitivity. This can even cause epigenetic changes, altering how genes related to stress and pain are expressed long-term. And immune activation. Yes, low-grade gut inflammation, increased numbers of immune cells like mast cells, releasing sensitizing chemicals, altered cytokine profiles, even potentially microglial activation and neuroinflammation within the CNS. These are all implicated in contributing to the sensitization and pain in DGBI. Okay, let's switch focus slightly to another major area. Chronic pelvic pain syndromes, C.P.P.S. How are these complex conditions being classified and understood now? Chronic pelvic pain generally defined as persistent or recurrent pain in the pelvis for more than three-six months is notoriously complex and heterogeneous. heterogeneous meaning lots of different presentations and causes. Exactly. The underlying pathophysiology is often poorly understood, which makes diagnosis and treatment really challenging. In men we often talk about chronic prosthetic chronic pelvic pain syndrome, C.P.C.P.P.S., or chronic scordal content pain, C.P.C.P. In women, common contributors or coexisting conditions include endometriosis, IDS, often comorbid, interstitial cystitis bladder pain syndrome, ICP.P.S., maybe sequelae of pelvic inflammatory disease, and a key point, multiple conditions often overlap in the same person. So it's rarely just one thing. Very often, yeah. Classification approaches have evolved. For prosthetitis, the NIH-developed categories, ICV, but specifically for male C.P.C.P.P.S., recognizing the heterogeneity, the U.point A system has become quite influential. U.point T, tell us about that. The U.point system was developed specifically to address the fact that C.P.C.P.P.S. isn't one single entity. It's a phenotyping system. It classifies patients based on different domains of their symptoms and clinical findings. Okay, what does U.point stand for? It stands for urinary symptoms, psychosocial factors, organ-specific findings, like prostate or bladder tenderness, infection evidence, neurologic systemic issues, and tenderness of pelvic floor muscles. Sometimes an S for sexuality issues is added, making it U.point A.P.S.P.S.P.S.P.S.P.S. So you assess each domain for each patient? Right. The clinician looks for positive findings in each domain. Research has shown that the more domains that are positive, the worse the patients overall symptoms tend to be. And how does this help with treatment? That's the real value. It guides multimodal individualized therapy. If the urinary domain is positive, you target that, e.g., alpha blockers. If psychosocial factors are prominent, you might use stress management, CBT, or antidepressants. Organ-specific might warrant anti-inflammatories, infection, antibiotics, if appropriate, neurologic, maybe neuromodulators, tenderness, pelvic floor physical therapy, sexuality issues addressed specifically. So, tailor the treatment to the patient-specific phenotype. Exactly. Studies support this approach, showing correlations between U.point scores and symptoms of erity. And importantly, suggesting that U.point A to therapy leads to better outcomes than a one-size-fits-all approach. So, like with the gut disorders, there's a trend away from just naming the organ, like prostatitis, as the sole explanation for pelvic pain. Definitely. There's a growing recognition of the limitations of purely end organ-nominclature. While specific conditions like endometriosis or actual prostatitis exist and cause pain, the chronic pain experience often involves more. The focus is shifting towards phenotypes, underlying mechanisms is neuropathic, myofascial, sexually-driven, and the significant role of psychosocial factors. Right. You even see terms like urologic chronic pelvic pain syndrome, UCPPS, being used in research, grouping conditions like ICBPS and CPCPPS, suggesting shared underlying mechanisms beyond just the bladder or prostate. And a huge factor is the high rate of comorbidity with other chronic overlapping pain conditions. Like IBS, fibromyalgia, exactly, IBS, fibromyalgia, ICBPS, endometriosis, mood disorders, chronic fatigue, despair, unia, painful sex, the often clustered together. This strongly suggests that for many people chronic pelvic pain might be part of a broader systemic pain/disregulation issue, with central sensitization playing a major role. And connections within the pelvis itself? Yes. There's evidence for visceral and somatovisceral convergence and cross-sensitization within the pelvis. And the trouble in the bladder might increase sensitivity in the bowel, or pelvic floor muscle tension might exacerbate bladder symptoms, for example. And again, the impact of psychological factors stress, anxiety, trauma history on pain perception and central sensitization in the context of pelvic pain is increasingly recognized as critical. This theme of moving beyond just naming an organ as the culprit seems really central to the evolution in understanding chronic visceral pain generally. Can you just summarize the core rationale for this paradigm shift towards symptom-based and mechanism-based classifications? Sure. The main drivers are the limitations of the traditional end organ approach. One, we often fail to find clear structural pathology that fully explains the pain. Two, even when we find something, the correlation between the finding, like mild inflammation, and the pain intensity is often poor. Three, there's huge symptom overlap between conditions traditionally defined by organ. Or diagnoses of exclusion can be deeply unsatisfying and invalidating for patients. Right being told nothing's wrong when you're in pain. Exactly. So, the advantages of symptom-based classifications, like the Rome Criteria for DGPI, they provide positive diagnostic criteria based on the patient's actual experience. This improves communication, research, and focuses on patient-reported outcomes. And mechanism-based classifications, like nasoplastic pain or UP&T. The advantage there is guiding targeted therapies. If we suspect the pain is primarily nasoplastic, centrally driven, we might use neuromodulators, if it seems inflammatory, anti-inflammatories. If myofascial, physical therapy, UP&T is a prime example of mechanism phenotype-guided therapy. It allows a deeper understanding of the pathophysiology and helps explain comorbidities through shared mechanisms like central sensitization. So, it was a fundamental redefinition. You could say that, chronic visceral pain is increasingly viewed less as just a symptom of organ damage, and more as a disorder of physiological regulation and sensory processing. It requires shifting from just find and fix the lesion to identify and modulate the dysregulated neurobiological systems. How does this shift impact diagnosis, research, and actual clinical management day-to-day? Diagnostically. Less reliant solely on structural tests after ruling out red flags, more emphasis on positive symptom criteria, functional assessments, psychosocial screening, and maybe looking for clinical signs of altered pain processing, like widespread sensitivity. Research. It allows for studying more homogenous patient groups based on symptoms or mechanisms which should yield clearer results, help find biomarkers, and accelerate understanding of pathophysiology, clinical management, strongly promotes multimodal multidisciplinary approaches. It encourages tailoring treatments using systems like UP&T or considering mechanisms like Nostleplastic Pain, and necessitates integrating pharmacological, psychological, physical, and lifestyle interventions. You've mentioned disorders of gut brain interaction, DGBI, several times. Can you just elaborate on why this concept itself is so powerful? GBI framework is powerful because it provides a unifying physiological model for these common, often disabling gut conditions that previously lacked clear structural explanations. It explicitly recognizes the dysregulation of that constant two-way communication between the CNS, brain spinal cord, and the ENS, the gut's nervous system. And the key factors in that dysregulation are? Altered gut motility, visceral hypersensitivity changes in mucosal immunity or low grade inflammation, puffs in the gut microbiota, and altered central nervous system processing, included the huge influence of stress, emotion, and cognition, brings all these pieces together. So it explains the symptoms without needing to find a hole in the gut lining, so to speak. Exactly. It provides a legitimate neurobiological basis for these symptoms. And while born from G.I. research, the core principles altered neural processing, brain body interactions, influences, systemic factors like stress and immunity are proving highly relevant for understanding other chronic visceral pain states, too, like many forms of chronic pelvic pain, where a similar gut brain or perhaps brain pelvis access dysregulation seems to be involved. Okay, let's wrap up by really drilling down on some of the key mechanistic insights we've gained. You've mentioned central sensitization and visceral hypersensitivity a lot. How do they relate? Are they the same thing? Good question. They're closely related, but not identical. Central sensitization is the broader phenomenon that amplification of neural signaling within the CNS, spinal cord and brain, leading to pain hypersensitivity. Remember, it causes aledinia, hyperalgesia, expanded receptive fields, pain lingering. It involves those NMDA receptors, ion channels, reduced inhibition, glial activation, et cetera, in the CNS. Okay, the central amplifier. Right. Visceral hypersensitivity is more specific. It's altered sensory processing related to the visceral, the internal organs. It manifests as a reduced pain threshold or exaggerated response, specifically to stimuli within those organs, like gut distension. It's a hallmark of many DGBI's, like IBS, and implicated in ICBPS2. And the mechanisms for VH? Can involve both peripheral sensitization, nerve endings in the gut wall becoming hyperexcitable due to local factors like inflammation or microbiota metabolites, and that central sensitization amplifying signals when they reach the spinal cord and brain. One peripheral sensitization might initiate the process, which then drives central sensitization. Once CS is established, it can amplify even normal peripheral signals, creating that vicious cycle. So they feed into each other? Very often, yes. And they both relate to nospastic pain. Nospastic pain is the clinical descriptor for pain thought to arise primarily from this altered central nospceptive processing without clear peripheral tissue damage driving it. peripheral hypersensitivity can be seen as a key manifestation or mechanism contributing to nospastic pain, specifically within the visceral system. Can you give that IBS example again to tie it together? Sure. Maybe someone has an initial get infection, peripheral trigger, causing inflammation and peripheral sensitization. This intense input drives central sensitization in the spinal cord brain. Even after the infection clears, the central sensitization persists. Now normal gut activity sends signals up, but they get amplified by the sensitized C&S, leading to ongoing pain and visceral hypersensitivity pain from normal function. That persistent pain driven by the altered central processing rather than ongoing gut damage is what we classify as nospastic pain. Okay. That clarifies the relationship. And what specific role does this concept of nospastic pain play across visceral disorders more broadly? Nospastic pain is defined by IASP is pain from altered nospicinal processing without clear evidence of actual tissue damage activating nospiceptors or a lesion disease of the somatosensory system causing the pain. So it's not classical nospiceptiv pain from injury and it's not classical neuropathic pain from nerve damage. It's this third category. Exactly. Clinically, it can feel dull, deep aching like nospiceptiv pain, but sometimes it might have burning or shooting qualities too, blurring lines with neuropathic. Key features often include variability, modulation by activity environment, emotion, and crucially often signs of widespread pain, hypersensitivity, alidinia, or hyperalgesia, even in areas seemingly unrelated to the main complaint. And other associated symptoms are common. Very, fatigue, unrefreshing sleep, cognitive issues, brain fog, sensitivity of light sound smell, mood disorders, these often accompany nospastic pain states. The IASP clinical criteria help identify it, pain three months, regional, nut discrete point distribution, pain not fully explained by nospiceptiv neuropathic mechanisms, and those clinical signs of hypersensitivity evoked during examination. And it's relevance to visceral pain. It's highly relevant. Many chronic primary visceral pain syndromes fit this picture. Think IBS, functional dyspepsia, CAPS, potentially some forms of chronic pelvic pain, like ICBPS or non-planetory CPCPPS. The idea is that the pain arises primarily from this altered central processing, the central sensitization, this nospastic mechanism, rather than ongoing damage or inflammation in the organ itself being the main driver. Okay. Finally, let's just circle back one last time to the brain gut access, the microbiota, the vagus nerve, the EPA stress axis. How do these pieces fit together in driving visceral pain? Right. The brain gut access BGA is that fundamental bidirectional communication network. Disregulation here is absolutely key, especially in DGBI, but likely relevant more broadly. So, microbial dysbiosis, the unbalanced gut bacteria. Yeah. Changes in the gut microbiome composition, diversity or function often seen in IBS, for example. This can, as we said, increase gut permeability, leaky gut, potentially allowing bacterial components like LPS to cross, trigger low grade inflammation, sensitize gut nerves, afference, and even influence the CNS. Plus, microbes produce neuroactive metabolites, SCFAs, serotonin precursors, GABA, that directly affect gut function, sensation, and consignal to the brain. And the vagus nerve's role in the dysfunction? It's the main highway. Altered afference signalling up the vagus from a disturbed gut environment can lead to abnormal brain processing of gut sensations. It's also involved in the descending colonergic anti-inflammatory pathway. If that's impaired, it could promote gut inflammation and pain. And the HPA access the stress connection. Chronic stress leads to HPA access dysregulation. Although acute cortisol is anti-inflammatory, chronic stress can lead to sustained cortisol or even glucocorticoid resistance, potentially becoming pro-inflammatory in the long run. C-R-H, the upstream regulator, directly mediates stress-induced visceral hypersensitivity, acting in brain areas like the amygdala. Stress can also cause those epigenetic changes we mentioned, altering stress-bane gene expression long-term. And the immune system links in too. Definitely. The BGA dysregulation activates immune cells, mass cells in the gut, releasing histamine and proteases that sensitize nerves. Microglial cells in the CNS, contributing to neuroinflammation. Pro-inflammatory cytokines like TNF-Alpha, IL-1 beta, IL-6 are often implicated. So it's this complex interplay? Exactly. The BGA is where top-down CNS stressors and bottom-up peripheral gut issues converge to cause and maintain chronic visceral pain. And because it's bi-directional, it means targeting either end might help. End-focus therapies like stress reduction or CBT? Or gut-focus therapies like diet, probiotics, maybe drugs targeting barrier integrity. They can both potentially modulate the entire axis and alleviate pain. This really provides the rationale for those integrated multimodal treatments addressing both top-down and bottom-up influences. This has been an incredibly detailed exploration. Phew. To bring our deep dive to a close, what are the absolute key takeaways listeners should hold on to? I think, firstly, just recognizing how much our understanding of visceral pain is evolving. Secondly, that crucial distinction between primary pain driven by altered processing and secondary pain driven by identifiable organ issues. Right. Thirdly, the shift toward symptom-based and mechanism-based classifications like DGBI and UPLAYON is really changing the game. And finally, understanding the central roles of, well, central sensitization, nasoplasic pain, and that incredibly complex brain-gut axis in driving these chronic conditions. And for those of you listening who might be living with these often really challenging conditions, we sincerely hope that this deeper understanding helps you feel, well, more informed about what might be going on and maybe feel a little less alone in your experience. Absolutely. And maybe a final thought to leave you with, given this incredibly intricate two-way communication between the brain and the gut, or the brain and the pelvis, what if future treatments focused less on just targeting the specific organ and more on actually harmonizing this complex communication system itself? What kinds of possibilities might that unlock for managing chronic pain down the road? That's a really thought-provoking question to end on. If you found this deep dive intriguing, we definitely encourage you to explore resources like the Rome Foundation's website or maybe look into some of the research on the gut microbiome. It's a fascinating field. And of course, as always, if you have concerns about your own health, please please don't guess them with your health care providers. Thanks for joining us for the Steve dive.